Peak HIV prevalence: a useful outcome variable for ecological studies  by Kenyon, Chris et al.
International Journal of Infectious Diseases 17 (2013) e286–e288Perspective
Peak HIV prevalence: a useful outcome variable for ecological studies
Chris Kenyon a,b,*, Robert Colebunders b, Helene Voeten c,d, Mark Lurie e
aDivision of Infectious Diseases and HIV Medicine, University of Cape Town, Anzio Road, Observatory 7700, South Africa
bClinical HIV/STD Unit, University of Antwerp, Institute of Tropical Medicine, Antwerp, Belgium
c Infectious Disease Control, Municipal Public Health Service, Rotterdam-Rijnmond, the Netherlands
dDepartment of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
e Brown University Medical School, Providence, Rhode Island, USA
A R T I C L E I N F O
Article history:
Received 26 October 2012
Received in revised form 16 December 2012
Accepted 22 December 2012







S U M M A R Y
A key question for ecological studies with HIV as the outcome variable is what measure of HIV prevalence
to use. In this study we compared the strengths and weaknesses of a variety of measures of HIV
prevalence, focusing on peak HIV prevalence and HIV prevalence measured at the same time as the
exposure variable. We explored the theoretical problems with each of the two measures of HIV
prevalence. We then investigated the difference that substituting one variable for the other made to two
published ecological studies. One published study found a strong relationship between migration
intensity and HIV prevalence measured at the time the migration was measured. When we repeated the
analysis using peak HIV prevalence as the outcome variable, there was no evidence of an association. The
second study found evidence of a strong relationship between concurrency and peak HIV prevalence. On
repetition of the analysis (but utilizing HIV prevalence at the time the concurrency was measured as the
outcome variable) there was no longer a signiﬁcant association. The choice of HIV measure as outcome
variable in ecological studies makes a large difference to the study results. The choice of peak HIV
prevalence as outcome variable offers the advantage of avoiding the HIV introduction time bias.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Population-level risk factors, such as increased network
connectivity, may be key to the generation of generalized HIV
epidemics (GHEs – deﬁned as adult (15–49 years old) HIV
prevalence 5%). Being population-level risk factors, they need
to be investigated at the population or ecological level. A key
question for ecological studies with HIV as the outcome variable is
what measure of HIV to use; for instance, incidence, prevalence,
peak prevalence, antenatal prevalence, or prevalence as measured
closest to the time of the exposure variable are all possible
measures of HIV that could be used.
A number of ecological studies have used HIV incidence,1
or prevalence at one point in time,2–4 as the outcome variable.
A reﬁnement of this approach has been to use HIV prevalence
at the date that the exposure variable was measured5,6 – here
termed date-of-exposure-variable (DEV) HIV prevalence. More
recently, studies have used national peak HIV prevalence as
the outcome variable.7,8 In this article, we use two empirical
examples to discuss the strengths and weaknesses of peak HIV* Corresponding author. Tel.: +27 21 404 9111; fax: +27 21 404 9113.
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ecological studies.
The use of DEV HIV prevalence follows in the tradition of
ecological studies of other infectious diseases.9 In diseases with
a short incubation and duration of symptoms followed by
recovery or death it is appropriate to measure the outcome
variable at a short time period after the exposure.9 In the case
of HIV this can be misleading for two reasons, as illustrated in
Figure 1. This ﬁgure represents the adult HIV prevalence for
Uganda and South Africa and the prevalence of two hypotheti-
cal causes of GHEs: E1 and E2.
The ﬁrst problem relates to the fact that even without
antiretroviral therapy (ART), infected persons remain as part of
the prevalent population of infected persons for around 10 years.10
The point prevalence of HIV in a population is therefore a product
of the interactions between its component causes over the
preceding decade or longer. Measuring Uganda’s HIV prevalence
in 1991, a year after the hypothetical exposure variable (E1), as is
commonly done in ecological studies, will result in ignoring the
effect of that variable on HIV prevalence in the years 1980–1989
(when most HIV infections occurred but E1 was 0). This could
result in a spurious association between E1 and HIV prevalence.
The use of peak HIV prevalence is also prone to this misclassiﬁca-
tion bias. Dealing with this problem requires either calculating ases. Published by Elsevier Ltd. All rights reserved.
Figure 1. The prevalence of HIV in Uganda and South Africa (RSA) (derived from
UNAIDS13 excluding Uganda’s prevalence pre-1990, which is from Kirby18) and two
hypothetical causal factors (E1 and E2) from 1980 to 2009.
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establishing that E is relatively stable over this time (such as E2).
A second problem and one that only affects DEV HIV prevalence,
is the HIV introduction time (HIT) bias. Countries with GHEs had
fairly similar rates of increase in HIV prevalence, but these
epidemics began at widely differing times, depending largely on
when the virus was introduced into the population.10 This is
illustrated in Figure 1, where South Africa’s epidemic only starts
around 1991, the same year that Uganda’s epidemic peaked. The
dashed line (E2) in the ﬁgure hypothetically represents the
prevalence of an established component cause of South Africa’s
HIV epidemic. If an ecological study of the relationship between E2
and HIV prevalence was made in 1989, it would likely miss the
association, as HIV prevalence is close to zero at this point. The
same study repeated a decade later, at the time of peak HIV
prevalence, would be less likely to miss the association. In an
ecological study seeking to uncover the determinants of GHEs it
would seem misleading to represent a country with a high peak
HIV prevalence such as South Africa as having an HIV prevalence of
0% merely because the exposure variable was measured in 1989.
The various component causes that made South Africa’s sexual
network so conducive to HIV spread were likely just as prevalent in
1989 (as attested to by the high rates of other sexually transmitted
infections) as in 2000.11 Using the peak HIV prevalence as the
outcome variable removes the bias introduced by the time of
introduction of HIV into a network. An alternative strategy that has
been used to deal with the HIT bias is to include, in multivariate
analysis, a variable that measures the time between the ﬁrst case of
HIV infection or AIDS in a country and the year the HIV prevalence
was measured.3,4 The problem with this approach relates to the
lack of evidence that this measure accurately measures the time of
introduction of HIV.12
We will now illustrate these problems with two examples from
the literature.
2. Examples
2.1. DEV HIV but not peak HIV prevalence, strongly associated with
migration
In this study, Voeten et al.,5 found evidence of a strong
association between female in-migration (percentage of 15–49-year-old women who migrated into major cities in 28 African
countries in the preceding 12 months) and urban antenatal HIV
prevalence in the same year (or if this was not available, then
adjacent years) (R2 = 0.57; p < 0.001). We repeated the same linear
regression analysis using the same datasets but using peak HIV
prevalence as the outcome variable and using female in-migration
prevalence closest to the year of peak HIV as the exposure variable.
In the repeat analysis there was no association between the two
variables (R2 = 0.085; p = 0.132).
2.2. Peak HIV but not DEV HIV prevalence, strongly associated with
concurrency
In this study, we found a strong association between point
prevalence of male concurrency and peak HIV prevalence at a
national level (R2 = 0.78; p < 0.001)7 in 11 countries where
concurrency data were collected in 1989. When we repeated the
analysis, with HIV prevalence in 1990 as the outcome variable, the
association between concurrency and HIV prevalence disappeared
(R2 = 0.04; p = 0.534).
3. Discussion
How should one go about deciding which of these results to
believe? We offer two arguments that suggest that in both cases
the results using peak HIV as outcome variable offer more plausible
results. The ﬁrst argument is methodological – unlike DEV, peak
HIV prevalence is not affected by the HIT bias.
In both of the studies above, the most noticeable determinant of
the dramatic changes in the relationship between HIV and the
exposure variable was the HIT bias. An example of this in the
concurrency study is that Lesotho in 1990 had an HIV prevalence of
0.8% and this was used in the DEV analysis. Only in 2000 did it
reach its peak HIV prevalence of 24.5%. Peak HIV was higher than
DEV HIV by a factor of three or more in the case of three other
countries – all of which had high concurrency rates. As with the
example of South Africa, it seems misleading to classify these four
countries as having an HIV prevalence so much lower than their
peak, simply because this was their HIV prevalence when the
surveys measuring concurrency rates were performed. Peak HIV
prevalence is by its nature a composite measure of all the factors
promoting and preventing the spread of HIV in a population that is
unaffected by the HIT bias. As such it represents a useful way to
compare risk factors underpinning the genesis of high HIV
prevalence rates.
Similarly in the migration study, Namibia was represented by
an HIV prevalence of 4.2%, which is what it was in 1992 when the
migration measurements were taken, rather than its peak of 16.5%.
There were also signiﬁcant discrepancies between the HIV
prevalence rates derived from antenatal statistics used in the
paper and the UNAIDS estimates of adult (15–49 years old)
prevalence data we used for the peak HIV estimates.13
The second argument is empirical. We have been unable to ﬁnd
an ecological association between migration and HIV prevalence in
analyses of 13 different measures of internal and international
migration (authors’ unpublished results). As far as the ecological
relationship between concurrency and HIV prevalence is con-
cerned, there has been considerable debate in the literature,14,15
but our study was the ﬁrst to evaluate this in a comparable cross-
country dataset. Further studies are however needed to better
understand these dynamics.
A potential newly arising problem in using peak HIV prevalence
is the effect of ART in increasing prevalence: by decreasing
mortality, ART will increase HIV prevalence. However, HIV
prevalence was declining in all countries that have experienced
GHEs before ART was in widespread use.13 In some countries HIV
C. Kenyon et al. / International Journal of Infectious Diseases 17 (2013) e286–e288e288prevalence is once again increasing due to ART/increasing HIV
incidence.13 This may make it more appropriate to use initial peak
HIV prevalence as the outcome variable.
While the HIT bias provides a strong rationale to use peak HIV
prevalence as outcome variable, much remains to be worked out
on how best to conduct ecological studies of the population-level
determinants of GHEs. In particular, thought needs to go into how
best to represent the strength of the exposure variable through the
period of increasing HIV prevalence. So too, it would be useful to
know the optimal way to include existing knowledge of
transmission matrices into models of HIV transmission. The
combination of the failure of individual-level studies to illuminate
the determinants of GHEs16 and the increasing evidence that
population-level factors may be responsible, make this an
important task.17,18
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